Superior efficacy of co-treatment with the dual PI3K/mTOR inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A against NSCLC

出版年份 2016 全文链接

标题

作者

关键词

Non-small-cell lung cancer, TSA, BEZ235, Epithelial-mesenchymal transition

出版物

Volume 7, Issue 37, Pages -

出版商

Impact Journals, LLC

发表日期

2016-08-06

DOI

10.18632/oncotarget.11109

联系作者

Explore over 38,000 international journals covering a vast array of academic fields.

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now